Denali Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage of Denali Therapeutics Inc was assembled by All Street Sevva using advanced Cognitive Robots. If you are employed by Denali Therapeutics Inc and you wish to licence your Sustainability rating, please contact us. Full Sustainability analysis of Denali Therapeutics Inc are reached by signing in.
Denali Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.6; made up of an environmental score of 1.3, social score of 1.1 and governance score of 5.3.
2.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1437 | Valenta Farmatsevtika AO | 2.7 | Medium |
| 1437 | Wockhardt Bio AG | 2.7 | Medium |
| 1481 | Denali Therapeutics Inc | 2.6 | Medium |
| 1481 | CTI Biopharma Corp | 2.6 | Medium |
| 1481 | Cannara Biotech Inc | 2.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Denali Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Denali Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Denali Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Denali Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Denali Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Denali Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Denali Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Denali Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Denali Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Denali Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Denali Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Denali Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Denali Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Denali Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Denali Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Denali Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Denali Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Denali Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.